Transcript Joey Wahler (Host): There are a hot topic right now, so were discussing GLP-1 medications
By placing a few drops under the tongue daily, you can experience the benefits of semaglutide in an easy-to-use, needle-free format
Scientific references TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial (NEJM, 2023) Retatrutide for people with type 2 diabetes a Phase 2 trial (The Lancet, 2023) LY3437943 (retatrutide), a triple GIP/GLP-1/glucagon agonist Phase 1b trial MHRA: avoid illegal online weight-loss medicines MHRA Drug Safety Update: GLP-1 / GIP agonists pancreatitis warnings NICE TA875: Semaglutide for overweight and obesity NICE TA1026: Tirzepatide for overweight and obesity Incretin-based drugs and gallbladder / biliary disease (The Lancet) Final word for UK research customers A retatrutide 40mg pen is a pre-filled, ready-to-use research peptide with 40mg in the tank roughly 240 clicks, enough for many small doses or a handful of big ones
Additionally, it decreases inflammation by reducing pro-inflammatory cytokines and increasing anti-inflammatory ones, thereby improving insulin sensitivity and decreasing tissue inflammation [41, 233]
Following these instructions will help you get the most out of your Semaglutide treatment